Septollete Total Eucalyptus, tablets 3 mg+1 mg 16 pcs

Symptomatic therapy of pain syndrome of inflammatory diseases of the oral cavity and ENT-organs (various etiology), including tonsillitis, pharyngitis, as part of the treatment.

Active ingredient

Composition

1 lemon and honey snuff tablet contains:

Active substances:

Benzidamine hydrochloride 3.000 mg

Cetylpyridinium chloride monohydrate 1.050 mg, equivalent to cetylpyridinium chloride 1.000 mg

Auxiliaries: isomalt (type M) (E953), citric acid (E330), sucralose (E955), honey flavoring, lemon flavoring, levomenthol, curcumin dye (E100)1), peppermint leaf oil

1) Curcumin dye (E100): curcumin (E100), maltodextrin, acacia gum (E414), emulsifier (E472c), citric acid (E330), potassium sorbate (E202), sodium benzoate (E211), purified water.

How to take, the dosage

The tablets should be taken slowly in the mouth every 3-6 hours.

Adults, elderly patientsand children over 12 years

The recommended dose is 3-4 tablets daily.

Children 6 to 12 years

The recommended dose is 3 tablets daily.

Do not exceed the indicated dose.

Septollete® total should not be used simultaneously with other drugs from the antiseptic group.

The drug Septollete® total should not be used more than 7 days.

Interaction

It has not been studied. Concomitant use with other drugs from the antiseptic group should be avoided.

Special Instructions

Hypersensitivity to acetylsalicylic acid or other non-steroidal anti-inflammatory drugs, bronchial asthma (including anamnesis).

Children over 12 years

The recommended dose is 3-4 tablets daily.

Children 6 to 12 years

The recommended dose is 3 tablets daily.

Contraindicated in children under 6 years.

Take with caution in patients with bronchial asthma (including history).

Elderly patients

The recommended dose is 3-4 tablets daily.

Septoleta® total should not be used more than 7 days. If there are no noticeable signs of improvement, a physician should be consulted.

When using Septoleta® total it is possible to develop hypersensitivity reactions. In this case it is recommended to stop the treatment and consult the doctor in order to prescribe an appropriate therapy.

In the presence of oropharyngeal ulceration, the patient should consult a physician if symptoms persist for more than three days.

The use of Septollete® total is not recommended in patients with hypersensitivity to acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs.

Septollete® total should not be used simultaneously with anionic compounds (such as those present in toothpaste). For optimal effect, do not use Septolete® total immediately before or after brushing teeth.

Concurrent administration with milk may decrease the antimicrobial effects of cetylpyridinium chloride; therefore, Septollete® total should not be used concomitantly with milk.

The drug Septolete® total has no effect on the ability to drive vehicles and operate machinery.

Synopsis

Circular tablets with beveled edges with a rough surface of light yellow to yellow. Allowed white coating, uneven color, the presence of air bubbles in the caramel mass and slight roughness of the edges.

Contraindications

Hypersensitivity to the active ingredients or any excipients of the drug.

Children under 6 years of age.

Side effects

World Health Organization (WHO) recommended side effect frequency classification:

very frequently ≥1/10

often ≥ 1/100 to < 1/10

infrequently from ≥ 1/1000 to < 1/100

rarely from ≥ 1/10000 to < 1/1000

very rarely < 1/10000

frequency is unknown cannot be estimated from available data.

Immune system disorders:

frequency unknown: hypersensitivity reactions, anaphylactic reactions.

Nervous system disorders:

frequency unknown: oral mucosa numbness.

Respiratory system, thoracic and mediastinal organs:

Rare: bronchospasm.

Gastrointestinal tract disorders:

very rarely: irritation of the oral mucosa, a burning feeling in the mouth.

Dermal and subcutaneous tissue disorders:

Rarely: hives, photosensitization;

frequency unknown: angioedema, skin itching.

Overdose

Symptoms:Toxic manifestations of benzidamine overdose include: agitation, seizures, increased sweating, ataxia, chills and vomiting. Signs and symptoms of intoxication when ingested in significant amounts of cetylpyridinium chloride: nausea, vomiting, edema, cyanosis, asphyxia with subsequent respiratory muscle paralysis, central nervous system depression, arterial hypotension and coma. The lethal dose for a human is about 1-3 grams.

Treatment: In the absence of a specific antidote, the treatment of acute benzidamine intoxication is symptomatic. Treatment of cetylpyridinium chloride overdose is also symptomatic. In case of overdose it is necessary to consult a doctor.

Pregnancy use

Pregnancy

Before using Septolete® total, if you are pregnant, or anticipate that you might be pregnant, or are planning to become pregnant, you should consult your physician.

Breastfeeding period

During the period of breastfeeding before using Septolete® total should be consulted with a doctor.

Similarities